Explorer les evidences

38 %Among 110 HIV-1-infected, drug-naïve Cameroonians, dual and triple PI resistance-associated substitutions were found in 38% of all strains.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

28,4 %The prevalence of obesity was 28.4% in the adult population aged 25 years and older in Biyem-Assi, Yaoundé, Cameroon.

Camerounobésitépublié 2015BMC public healtheurope_pmcdocument de 5 observations

30 %Among classifiable protease (PR) sequences from HIV-1-infected, drug-naïve Cameroonians, 30% had dual and triple PI resistance-associated substitutions.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

80 %Sensitivity for the detection of severe nonproliferative diabetic retinopathy using the smartphone-based retinal camera was 80%.

Camerounsevere nonproliferative diabetic retinopathypublié 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument de 16 observations

41,2 %Urban participants were more likely to have diabetes (41.2%) compared to rural participants (7.2%).

Cameroundiabète (non précisé)publié 2009Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument de 5 observationsDOI 10.1111/j.1751-7176.2009.00165.x

71 mmHgThe mean diurnal diastolic blood pressure was 71 ± 7 mmHg in the diabetic group.

Cameroundiabète de type 1publié 2017World journal of diabeteseurope_pmcdocument de 9 observations

4 454 adults4,454 adults were screened for hypertension.

Camerounhypertension artériellepublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

12,7 %Une étude menée au Cameroun a révélé que 12,7 % des participants avaient une pression artérielle élevée.

Camerounpression artérielle élevéeobservé 2012HAL · Unilimdocument de 857 observations

2,3 odds_ratioThe combined effect of diabetes mellitus on tuberculosis risk was an odds ratio of 2.3 with a 95% confidence interval of [2.0–2.7].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

58 %Training improved insulin sensitivity by 58% in middle-aged men with type 2 diabetes.

Cameroundiabète de type 2publié 2003European journal of endocrinologyeurope_pmcdocument de 3 observationsDOI 10.1530/eje.0.1490421

1 380 cells/mm³A male chimpanzee (Cam155), 1.5 years old, showed a significant decline of CD4 counts from 1,380 cells/mm³ in 2004 to 287 cells/mm³ in 2009.

CamerounSIVcpzobservé 2004publié 2011RetrovirologyOpenAlexdocument de 4 observationsDOI 10.1186/1742-4690-8-4

158 mmHgAfter one month of alternative treatment, office blood pressure in the control group decreased from 158 ± 8/94 ± 8 mmHg to 144 ± 17/89 ± 12 mmHg in Cameroonian type 2 diabetic patients with resistant hypertension.

Cameroundiabète de type 2 · resistant hypertensionpublié 2016BMC research noteseurope_pmcdocument de 5 observations

24,2 %Of those screened for hypertension, 24.2% had elevated blood pressure and were linked to care centers.

Camerounhypertension artériellepublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

1,53 mg/LNon-surgical periodontal treatment decreased serum C reactive protein level in individuals without diabetes with chronic periodontitis, from 2.35 (1.46–4.18) mg/L before treatment to 1.53 (1.03–2.12) mg/L after treatment, with p=0.033.

CamerounPeriodontitispublié 2021Journal of investigative medicine : the official publication of the American Federation foeurope_pmcdocument de 2 observationsDOI 10.1136/jim-2021-001831

11 %The prevalence of the 10I substitution in protease sequences was 11% (6/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

57 yearsThe mean age of patients presenting with diabetic foot was 57 years with a standard deviation of 9 years.

Camerounpied diabétiquepublié 2005Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 10 observations

11,9 odds_ratioPeople with type 2 diabetes had greater odds of being hospitalised (OR 11.9 [95% CI: 1.6–87.9]) compared with people without diabetes.

Cameroundiabète de type 2publié 2017BMC health services researcheurope_pmcdocument de 7 observationsDOI 10.1186/s12913-017-2197-0

There was a significant trend towards a positive change in waist-to-hip ratio with increasing duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.

CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations

24,9 %The estimated global lifetime risk of stroke from the age of 25 years onward was 24.9% in 2016.

CamerounAVCobservé 2016publié 2018The New England journal of medicineeurope_pmcdocument de 12 observations

98,5 %HIV-1 group M prevalence in Cameroon was 98.5%.

CamerounHIV-1 group Mobservé 2006 to 2013publié 2015Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument de 4 observations

2 %The prevalence of the 312Q substitution in reverse transcriptase sequences was 2% among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

95 msQRS duration increased between D0 and D7 (95±10 ms versus 102±17 ms, p = 0.004).

CamerounCOVID-19observé 2020publié 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument de 6 observationsDOI 10.1101/2020.06.24.20139386

7,8 %Seroprevalence in insectivorous Molossidae family species ranged from 7.8% to 8.9%.

Camerounarbovirusespublié 2022Vector borne and zoonotic diseases (Larchmont, N.Y.)europe_pmcdocument de 9 observations

2 odds_ratioThe odds ratio for tuberculosis risk in cohort studies with diabetes mellitus was 2.0 with a 95% confidence interval of [1.5–2.4].

Cameroundiabète (non précisé) · tuberculosepublié 2021PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0261246

Erycristagallin had no effect on cyclooxygenase-1 metabolism in human platelets.

Camerouncyclooxygenase-1 metabolism in human plateletspublié 2003European journal of pharmacologyeurope_pmcdocument de 5 observations